HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming-Chung Wang Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

12/2021Role of quantitative hepatitis B surface antibodies in preventing hepatitis B virus-related hepatitis in patients treated with rituximab.
1/2021Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial.
7/2012Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy.
3/2010Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming-Chung Wang Research Topics

Disease

5Hepatitis B
12/2021 - 01/2002
5Hepatitis
12/2021 - 01/2002
5Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2021 - 01/2002
5Neoplasms (Cancer)
01/2018 - 03/2008
4Multiple Myeloma
01/2022 - 03/2010
4Infections
12/2021 - 01/2002
4B-Cell Lymphoma (Lymphoma, B Cell)
12/2021 - 03/2010
4Lymphoma (Lymphomas)
01/2021 - 03/2008
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2013 - 06/2007
2T-Cell Lymphoma (Lymphoma, T Cell)
10/2019 - 12/2018
2Peripheral Nervous System Diseases (PNS Diseases)
10/2014 - 03/2010
2Thrombocytopenia (Thrombopenia)
10/2014 - 03/2010
1Hemolysis
05/2021
1Hypertension (High Blood Pressure)
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Fibrosis (Cirrhosis)
01/2018
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2017
1Citrullinemia
12/2017
1Skin Diseases (Skin Disease)
03/2016
1Lymphadenopathy
03/2016
1Erectile Dysfunction
01/2016
1Dyspnea (Shortness of Breath)
01/2016
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2015
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2015
1Hemorrhage
12/2015
1Splenomegaly
07/2015
1Primary Myelofibrosis (Myelosclerosis)
07/2015
1Albuminuria
04/2015
1Diabetic Nephropathies (Diabetic Nephropathy)
04/2015
1Anemia
04/2015
1Lymphopenia (Lymphocytopenia)
10/2014
1Asthenia
10/2014
1Fatigue
10/2014
1Cytopenia
01/2014
1Epstein-Barr Virus Infections
01/2013
1Disease Progression
01/2013
1Leukemia
11/2011

Drug/Important Bio-Agent (IBA)

6Rituximab (Mabthera)FDA Link
12/2021 - 03/2010
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 10/2014
3Hemoglobins (Hemoglobin)IBA
05/2021 - 04/2015
3Hepatitis B Surface Antigens (HBsAg)FDA Link
06/2014 - 01/2002
3Lamivudine (Epivir)FDA Link
03/2010 - 01/2002
2AntibodiesIBA
12/2021 - 07/2012
2Pharmaceutical PreparationsIBA
01/2021 - 10/2014
2Immunoglobulin G (IgG)IBA
01/2018 - 03/2016
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2016 - 01/2014
2Bortezomib (Velcade)FDA Link
10/2014 - 03/2010
2Imatinib Mesylate (Gleevec)FDA Link
01/2013 - 11/2011
1pomalidomideIBA
01/2022
1isatuximabIBA
01/2022
1fibrin fragment D (D-dimer)IBA
05/2021
1Protein CIBA
05/2021
1Antithrombin IIIIBA
05/2021
1Biological ProductsIBA
05/2021
1Fibrinogen (Factor I)FDA Link
05/2021
1Monoclonal AntibodiesIBA
01/2021
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2021
1copanlisibIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
10/2019
1FibrinIBA
01/2018
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1Arginine (L-Arginine)FDA Link
12/2017
1arginine deiminaseIBA
12/2017
1ADI PEG20IBA
12/2017
1Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA
12/2017
1Lenalidomide (CC 5013)FDA Link
09/2017
1AutoantibodiesIBA
03/2016
1Interferon-gamma (Interferon, gamma)IBA
03/2016
1Inosine Triphosphate (ITP)IBA
12/2015
1eltrombopagFDA Link
12/2015
1Glycoproteins (Glycoprotein)IBA
12/2015
1Thrombopoietin ReceptorsIBA
12/2015
1Bendamustine HydrochlorideFDA Link
12/2015
1Janus Kinase InhibitorsIBA
07/2015
1Janus Kinase 1IBA
07/2015
1ruxolitinibIBA
07/2015
1ErythropoietinFDA Link
04/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2015
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2015
1Serum AlbuminIBA
04/2015
1PanobinostatIBA
10/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2014
1DNA (Deoxyribonucleic Acid)IBA
06/2014
1Antiviral Agents (Antivirals)IBA
06/2014
1Alanine Transaminase (SGPT)IBA
06/2014
1Prednisolone (Predate)FDA LinkGeneric
06/2014
1Vincristine (Oncovin)FDA LinkGeneric
06/2014
1entecavirFDA Link
06/2014
1RNA (Ribonucleic Acid)IBA
01/2013
1Tyrosine Kinase InhibitorsIBA
01/2013
1Transcription Factors (Transcription Factor)IBA
11/2011
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2011
1CateninsIBA
11/2011
1CarcinogensIBA
11/2011
1Tyrosine (L-Tyrosine)FDA Link
02/2011

Therapy/Procedure

11Therapeutics
12/2021 - 01/2002
7Drug Therapy (Chemotherapy)
12/2021 - 01/2002
1Intravenous Infusions
01/2021
1Aftercare (After-Treatment)
12/2015